PFA

Auditor Resigned MidtermManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.59

prior close

₹0.59

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-1.0% vs market

Other Financial Services peers, median of 83sector+0.0%+0.0% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and in line with its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+0.0

15m

-1.7

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+1.0-1.0+0.0+0.0

Next day

+0.0+0.5-0.5+0.0+0.0

+1.7-0.0+1.7+0.0+1.7

+1.7-1.5+3.2-0.3+2.0

+0.0-2.2+2.2-0.5+0.5

+0.0-1.2+1.2-0.8+0.8

-1.7-2.4+0.7-2.6+0.9

15d

-8.5-8.8+0.4-5.8-2.7

-11.9-8.3-3.6-4.7-7.2

-27.1-3.5-23.6-1.5-25.6

-35.6+6.4-42.0+2.1-37.7

UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 83Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biogen Pharmachem Industries has informed BSE that its Statutory Auditor, M/s Rishi Sekhri and Associates (Chartered Accountants, Membership No. 126656), has resigned effective 9th February 2026. The auditor cited significant medical conditions as the reason and explicitly stated there are no other circumstances connected with the resignation. The auditor was appointed on 25 September 2025 with a term scheduled to run until 31 March 2030, making this a mid-term exit. The last audit/limited review report was submitted on 7 November 2025. The auditor raised no concerns with management and has no objection to another chartered accountant being appointed in their place.

Likely market impact

Although this is a mid-term auditor resignation, the stated reason is medical and no governance concerns were flagged, which limits red flags. Shareholders should watch for timely appointment of a new statutory auditor to ensure uninterrupted audit coverage and compliance.